Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Barts Health Nhs Trust currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner working within 1 distinct art unit. The current portfolio activity is limited to these specific parameters. This concentration allows the applicant to focus resources on a specific set of examiner preferences rather than managing requirements across multiple technical fields. The trust's focus on 1 examiner interaction simplifies the administrative tracking of its pending biotechnology matters.
The busiest examiner for this portfolio is KARUNASENA, ENUSHA, who is responsible for 1 busiest examiner pending office action. Because this individual accounts for the 1 pending office action reported for the entire trust, the prosecution strategy is currently dependent on 1 examiner interaction. Practitioners should focus on the specific history of this examiner to resolve the outstanding action. Successfully navigating this 1 distinct art unit is the path to securing the trust's current intellectual property objectives in the biotechnology sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 25.0% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715512 | METHODS FOR DIAGNOSING OR PREDICTING A CARDIAC INFLAMMATORY CONDITION | KARUNASENA, ENUSHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715512 | METHODS FOR DIAGNOSING OR PREDICTING A CARDIAC INFLAMMATORY CONDITION | KARUNASENA, ENUSHA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18715512 | METHODS FOR DIAGNOSING OR PREDICTING A CARDIAC INFLAMMATORY CONDITION | KARUNASENA, ENUSHA | 1653 | §101§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBarts Health Nhs Trust has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Enusha Karunasena has the most, with 1 of Barts Health Nhs Trust's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
